The global Avenanthramides Market was valued at USD 145.1 million in 2025 and is projected to reach USD 158.7 million by 2026. Experts forecast the market to expand significantly to USD 389.8 million by 2036, progressing at a 9.4% CAGR.Traditionally niche oat-derived compounds, avenanthramides have transitioned into mainstream dermatological pipelines. This shift is driven by a...